We have officially partnered with ROKIT_Official, closing as a major Series C investor. Rokit is ushering the future of regenerative medicine with its customized artificial organ platform, and we are honored to be a part of that journey! #Innovation #Biotechnology #VentureCapital

🚨 Check out our press release on Bloomberg! We believe in the ROKIT_Official team who are being guided by the visionary leadership of their CEO, Steve SH You. True pioneers in the field of organ regeneration! #Bloomberg #VentureCapital #innovation bloomberg.com/press-releases…

We are absolutely delighted to hear about this great news from AZTherapies. As major shareholders of AZT we look forward to many more milestones from this amazing company that will definitely change the game for neurodegenerative disease therapeutics. aztherapies.com/2020/09/29/azt…

📢 Exciting news from AZTherapies! We believe that Marc de GARIDEL will be an amazing CEO for AZTherapies. We look forward to all the progress AZT will make under Marc's guidance. #biotech #VentureCapital #Pharmaceutical aztherapies.com/2020/10/01/azt…

We have officially partnered with @HyperfineR, closing as a Series D investor. Hyperfine is introducing a completely new dimension to patient care with their portable MRI. We are honored to be a part of their mission of democratizing healthcare. #innovation #VentureCapital

We are excited to announce that we have invested in Zammoai! Zammo's solution tackles the lack of connectedness between voice enabled services, enabling cross-talk between different voice activated technologies. Applicable across many fields, Zammo will be a real game changer.

Hyperfine Raises $90 Million in Oversubscribed Series D Financing Raised capital from GV Krishna Yeshwant Antonio Silveira DRADS Capital Altium Capital Bill Perkins (Guy) and others as we continue to democratize healthcare for all patients #MRI #Radiology bit.ly/3cZpjQ3

We are happy to announce that we have invested in Amylyx! We look forward to working with them and witnessing their game-changing approaches to therapeutics. #pharma #biotech #VentureCapital

At DRADS, we invest in brilliant people with transformative ideas to solve difficult problems. The Live Green Co checks these boxes in building the #futureoffood, and we are delighted to lead their Series Pre-A! Announcement: bit.ly/livegreen-prea